Background: Hemophagocytic lymphohistiocytosis (HLH) and sepsis frequently appear as overlapping diagnoses in intensive care units. It is necessary to distinguish HLH, which has a very high mortality, from sepsis. In this study, we wanted to draw attention to the potential of procalcitonin (PCT) and C-Reactive Protein (CRP) as a marker like ferritin in differential diagnosis. Thus, HLH can be diagnosed as early as possible and the necessary aggressive immunosuppressive therapy can be added to the existing treatment.
Methods: All of the patients in the sepsis clinic who meet the HLH criteria Group HLH; patients not meeting the HLH criteria were defined as Group non-HLH. Files of all patients were reviewed in regard to HLH diagnosis criteria and H score.
Results: There were 16 patients in Group HLH and 15 in Group non-HLH. CRP and PCT levels were significantly lower (p: 0.007 and p<0.001, respectively) and ferritin levels were higher (p<0.001) in Group HLH. Hyperferritinemia was present in 15 (94%) and hemophagocytosis in bone marrow in 10 (63%) patients. In group HLH patients, the H score was 258 (230.7-281.5).
Conclusion: In critically ill children with suspected sepsis, if CRP and PCT values- two of acute phase reactants- do not explain the patient's poor clinical condition, HLH, which is an often overlooked diagnosis, must be excluded.
ferritin; Hemophagocytic lymphohistiocytosis Children procalcitonin; sepsis
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Original Articles |
Yazarlar | |
Yayımlanma Tarihi | 13 Haziran 2022 |
Gönderilme Tarihi | 4 Mart 2022 |
Yayımlandığı Sayı | Yıl 2022 Cilt: 49 Sayı: 2 |